U.S. FDA In Search Of New Diagnostic Tests For Neglected Tropical Diseases
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA's diagnostics staff is asking companies developing multiplex tests to "slip in" some assays to test for neglected tropical diseases, which affect one-sixth of the world's population, primarily in developing countries